Position in XENE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$99,162,305
+$63,918,463 QoQ
Shares Held
1,642,848
+171.1% QoQ
Ownership
1.70%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#12
of 314 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,273,657,992 across 342 Biotechnology names. XENE ranks #19 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in XENE
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $99,162,305 | 1,642,848 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $35,243,842 | 606,085 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $19,574,821 | 436,743 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $7,950,779 | 236,983 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $10,715,398 | 273,352 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,589,705 | 243,579 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,608,079 | 195,129 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $11,822,649 | 274,626 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $15,661,090 | 340,015 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,754,423 | 80,633 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $717,370 | 18,633 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $409,938 | 11,454 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $2,020,661 | 55,974 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $7,112,110 | 232,650 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $8,695,435 | 278,343 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,592,649 | 169,676 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,586,759 | 85,218 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,373,037 | 76,706 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $777,628 | 50,561 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $553,333 | 49,985 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,506,242 | 120,115 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,004,780 | 88,605 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||